13F Filings History of Enavate Sciences GP, LLC

Latest 13F filing: Q2 2026 - 14 Aug 2026
Latest reported 13F value: $345,377,333
Largest 13F holdings: SION ZBIO IMNM BBOT CMPX UPB CAMP
Form 13F summary: Enavate Sciences GP, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
Form 13F is generally due within 45 days after each calendar quarter ends.
Enavate Sciences GP, LLC reported 7 equity holdings with a total reported market value of $345,377,333 for Q2 2026. Top reported holdings included SION, ZBIO, IMNM, BBOT, and CMPX.
Manager signature: James P. Boylan - Chief Executive Officer
Manager location: New York, NY

Follow Filing Activity

Follow Enavate Sciences GP, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter

Q2 2026

Latest value

$345,377,333

Quarter delta

-$6,129,997

Accepted

14 Aug 2026, 16:32

Rows shown

1-7 of 7

Quarter	Holdings	SEC-reported value	Bought	Sold	Net	Top Holdings	Form Type	Accepted by SEC
Q2 2026	7	$345,377,333	$0	-$3,344,706	-$3,344,706	SION, ZBIO, IMNM, BBOT, CMPX	13F-HR	14 Aug 2026, 16:32
Q1 2026	7	$351,507,330	$0	-$28,981,157	-$28,981,157	SION, IMNM, ZBIO, CMPX, BBOT	13F-HR	15 May 2026, 16:20
Q4 2025	7	$506,782,253	+$5,729,718	-$4,597,359	+$1,132,359	ZBIO, IMNM, SION, UPB, CMPX	13F-HR	17 Feb 2026, 16:21
Q3 2025	7	$327,524,118	+$30,420,035	$0	+$30,420,035	ZBIO, SION, IMNM, UPB, BBOT	13F-HR	14 Nov 2025, 16:16
Q2 2025	6	$176,535,354	$0	$0	$0	IMNM, SION, ZBIO, UPB, CMPX	13F-HR	14 Aug 2025, 16:18
Q1 2025	6	$132,721,569	+$34,604,061	$0	+$34,604,061	IMNM, ZBIO, SION, CAMP, UPB	13F-HR	15 May 2025, 16:17
Q4 2024	5	$139,236,883	$0	$0	$0	UPB, IMNM, ZBIO, CAMP, CMPX	13F-HR	14 Feb 2025, 16:15